Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8017114 Human CTLA-4 antibodies and their uses

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 22, 2009
0
Date of Patent
September 13, 2011
0
Patent Application Number
12564756
0
Patent Citations Received
‌
US Patent 12076375 Treating and preventing
0
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
‌
US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
0
‌
US Patent 11788085 Treating and preventing microbial infections
‌
US Patent 11779619 Oncolytic virus for expression of immune checkpoint modulators
‌
US Patent 12090183 Methods of treating solid or lymphatic tumors by combination therapy
0
‌
US Patent 12128018 Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
0
Patent Inventor Names
Nils Lonberg
0
Alan J. Korman
0
Edward L. Halk
0
Tibor P. Keler
0
Yashwant M. Deo
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8017114
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 8017114 Human CTLA-4 antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.